Science Explorer Interactive view Map
Company · Seongnam-si · South Korea

Qurient (South Korea)

qurient.comROR OpenAlex
Research works
29
▲ 360% vs 2013–17
Citations
263
9.0 per fractional work
Top-10% rate
6.1%
record average 16.5%
Open access
20%
world 28%

Not ranked overall: Qurient (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.50× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 20.30× its world share, 2 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 18.91× its world share, 1 worksPharmacology, Toxico…Computer Science: 0.60× its world share, 0 worksComputer ScienceEngineering: 0.51× its world share, 1 worksEngineeringHealth Professions: 0.20× its world share, 0 worksHealth ProfessionsMedicine: 1.87× its world share, 3 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 20.3×. Every wedge is a field page.

Which keywords describe research at Qurient (South Korea)?

By fractional works in all years, weighted toward what it does more of than the world: apoptotic cells, CD47, Breast Cancer, Metastatic Breast Cancer, CDK4/6 Inhibitors, Palbociclib, Cancer Therapy and Chemotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 35 words, with their numbers
  1. CD472▲ 561×1 topic
  2. apoptotic cells2▲ 561×1 topic
  3. Breast Cancer2▲ 25×2 topics
  4. Inflammation2▲ 2.9×5 topics
  5. Metastatic Breast Cancer2▲ 101×2 topics
  6. CDK4/6 Inhibitors2▲ 409×1 topic
  7. Palbociclib2▲ 409×1 topic
  8. Cancer Therapy2▲ 9.6×5 topics
  9. Remote Sensing2▲ 5.2×4 topics
  10. Cancer2▲ 4.0×3 topics
  11. Chemotherapy2▲ 7.9×5 topics
  12. Epidemiology1▲ 1.22×5 topics
  13. Treatment1▲ 3.7×5 topics
  14. Activation1▲ 128×1 topic
  15. Artificial Intelligence1▲ 5.5×2 topics
  16. Diagnosis1▲ 4.3×3 topics
  17. Macrophage1▲ 80×1 topic
  18. Atherosclerosis1▲ 11×3 topics
  19. Cancer Progression1▲ 17×2 topics
  20. Deep Learning1▲ 1.88×2 topics
  21. Immune Response1▲ 6.8×4 topics
  22. Pharmacokinetics1▲ 14×3 topics
  23. Antioxidant1▲ 5.8×2 topics
  24. Regulation1▲ 6.2×2 topics
  25. Asset Pricing1▲ 25×1 topic
  26. Cell Cycle1▲ 61×1 topic
  27. DNA1▲ 109×1 topic
  28. Ginkgo Biloba1▲ 381×1 topic
  29. Ideological Education1▲ 91×1 topic
  30. Monetary Equilibrium1▲ 70×1 topic
  31. Neuroprotective1▲ 28×1 topic
  32. Political Education1▲ 91×1 topic
  33. Targeted Therapy1▲ 16×5 topics
  34. Topoisomerases1▲ 109×1 topic
  35. p531▲ 80×1 topic

Which research topics does Qurient (South Korea) publish most on?

By volume in 2022–2025: RNA modifications and cancer, Phagocytosis and Immune Regulation, Immune cells in cancer and Cancer therapeutics and mechanisms.

RNA modifications and cancer: 1 fractional worksPhagocytosis and Immune Regulation: 1 fractional worksImmune cells in cancer1Immune cells in cancer: 1 fractional worksCancer therapeutics and …0Cancer therapeutics and mechanisms: 0 fractional worksCancer-related Molecular Pathways: 0 fractional worksUbiquitin and proteasome pathways: 0 fractional worksImmune Cell Function and…0Immune Cell Function and Interaction: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksAdvancements in Transdermal Drug Delivery: 0 fractional worksRadiopharmaceutical Chemistry and Applications: 0 fractional works
Molecular BiologyImmunologyOncologyRadiology, Nuclear Medicine and Imaging1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 RNA modifications and cancer Molecular Biology 1 works
  2. 2 Phagocytosis and Immune Regulation Immunology 1 works
  3. 3 Immune cells in cancer Immunology 1 works
  4. 4 Cancer therapeutics and mechanisms Molecular Biology 0 works
  5. 5 Cancer-related Molecular Pathways Oncology 0 works
  6. 6 Ubiquitin and proteasome pathways Molecular Biology 0 works
  7. 7 Immune Cell Function and Interaction Immunology 0 works
  8. 8 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  9. 9 Advancements in Transdermal Drug Delivery Pharmaceutical Science 0 works
  10. 10 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available19.5%not open80.5%

World: 28% of research is openly available.

with international co-authors16.0%domestic only84.0%

World: 19% is written across borders.

How has Qurient (South Korea)'s research output changed?

Output in 2018–2022 was 360% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seongnam-si

All research institutions in Seongnam-si

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.